Public Calendar: November 10-16, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Brett P. Giroir, M.D, Acting Commissioner of Food and Drugs
Event Date: 11/13/2019
Location: Silver Spring, MD
Subject: Cancer Research (Telephone Call)
FDA Participant/Group: KEAGAN LENIHAN;
Non FDA Participant/Group: Harry Reid (Former Senator);
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
Event Date: 11/13/2019
Location: Los Angeles, CA
Subject: a16z Summit 2019; A Fireside Chat With Amy Abernethy - Innovation in Medicine, Healthcare, and Policy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, academia, and the media
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
No Significant Event
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
Event Date: 11/11/2019
Location: New Delhi, India
Subject: India Pharmaceutical and Good Manufacturing Processes (GMP) Issues
FDA Participant/Group: N/A
Non FDA Participant/Group: 4th Indian Pharmaceutical Alliance Advanced GMP Workshop attendees
Event Date: 11/13/2019
Location: New Delhi, India
Subject: Indian Food and Medical Product Exports
FDA Participant/Group: N/A
Non FDA Participant/Group: Gujarat Food and Drug Control Administration representatives
Event Date: 11/14/2019
Location: New Delhi, India
Subject: India Pharmaceutical Manufacturing and Quality
FDA Participant/Group: N/A
Non FDA Participant/Group: 3rd Annual Regulatory Forum and Bilateral Meeting with Government of India Central Drug Standard Control Organization (CDSCO) representatives
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date: 11/15/2019
Location: College Park, MD
Subject: Meeting with American Cheese Society (ACS)- Various Food Issues
FDA Participant/Group: WILLIAM CORRELL; JENNIFER DOOREN; JOHN SHEEHAN; PAUL SOUTH; MICKEY PARISH;
Non FDA Participant/Group: N/A
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event